Raut M - Search Results

1

Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study.

Zilberberg MD, Carter C, Lefebvre P, Raut M, Vekeman F, Duh MS, Shorr AF. Zilberberg MD, et al. Among authors: raut m. Crit Care. 2007;11(3):R63. doi: 10.1186/cc5934. Crit Care. 2007. PMID: 17553147 Free PMC article.

2

Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer.

Smith MR, Boyce SP, Moyneur E, Duh MS, Raut MK, Brandman J. Smith MR, et al. J Urol. 2006 Jan;175(1):136-9; discussion 139. doi: 10.1016/S0022-5347(05)00033-9. J Urol. 2006. PMID: 16406890

3

A survey-based assessment of the prevalence and severity of chronic hand dermatitis in a managed care organization.

Fowler JF, Duh MS, Chang J, Person J, Thorn D, Raut M, Ghosh A, Den E, Emani S. Fowler JF, et al. Among authors: raut m. Cutis. 2006 Jun;77(6):385-92. Cutis. 2006. PMID: 16838772

4

Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United States.

Yang X, Laliberté F, Germain G, Raut M, Duh MS, Sen SS, Lejeune D, Desai K, Armand P. Yang X, et al. Among authors: raut m. J Med Econ. 2021 Jan-Dec;24(1):469-478. doi: 10.1080/13696998.2021.1908001. J Med Econ. 2021. PMID: 33784916 Free article.

5

Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA.

Laliberté F, Raut M, Yang X, Germain G, Nahar A, Desai KD, MacKnight SD, Sen SS, Duh MS. Laliberté F, et al. Among authors: raut m. Target Oncol. 2021 Jan;16(1):85-94. doi: 10.1007/s11523-020-00778-y. Target Oncol. 2021. PMID: 33284424 Free PMC article.

6

Real-World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B-Cell Lymphoma in the U.S.

Yang X, Laliberté F, Germain G, Raut M, Duh MS, Sen SS, Lejeune D, Desai K, Armand P. Yang X, et al. Among authors: raut m. Oncologist. 2021 May;26(5):e817-e826. doi: 10.1002/onco.13721. Epub 2021 Mar 15. Oncologist. 2021. PMID: 33616256 Free PMC article.

7

Rates of hospitalization among patients with deep vein thrombosis before and after the introduction of rivaroxaban.

Merli GJ, Hollander JE, Lefebvre P, Laliberté F, Raut MK, Olson WH, Pollack CV Jr. Merli GJ, et al. Hosp Pract (1995). 2015;43(2):85-93. doi: 10.1080/21548331.2015.1021659. Epub 2015 Mar 19. Hosp Pract (1995). 2015. PMID: 25791984 Clinical Trial.

8

Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?

Laliberté F, Pilon D, Raut MK, Nelson WW, Olson WH, Germain G, Schein JR, Lefebvre P. Laliberté F, et al. Curr Med Res Opin. 2014 Aug;30(8):1521-8. doi: 10.1185/03007995.2014.916159. Epub 2014 May 2. Curr Med Res Opin. 2014. PMID: 24758611

9

Hospital length of stay of nonvalvular atrial fibrillation patients who were administered Rivaroxaban versus Warfarin with and without pretreatment parenteral anticoagulants therapies.

Laliberté F, Pilon D, Raut MK, Nelson WW, Olson WH, Germain G, Schein JR, Lefebvre P. Laliberté F, et al. Hosp Pract (1995). 2014 Aug;42(3):17-25. doi: 10.3810/hp.2014.08.1114. Hosp Pract (1995). 2014. PMID: 25255403

10

Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patients with non-valvular atrial fibrillation?

Laliberté F, Pilon D, Raut MK, Nelson WW, Olson WH, Germain G, Schein JR, Lefebvre P. Laliberté F, et al. Curr Med Res Opin. 2014 Apr;30(4):645-53. doi: 10.1185/03007995.2013.867843. Epub 2013 Dec 5. Curr Med Res Opin. 2014. PMID: 24256067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters